Atlas Trials

TMC207 +/- Rifabutin/Rifampin

Clinical trial NCT01341184 · COMPLETED

Trial details

NCT number
NCT01341184
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2011-10-21
Primary completion
2012-05-23
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.